Victoria L. Creamer's most recent trade in Charles River Laboratories International Inc. was a trade of 6,252 Common Stock done at an average price of $135.6 . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 135.63 per share. | 30 May 2025 | 6,252 | 22,482 (0%) | 0% | 135.6 | 847,959 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.63 per share. | 30 May 2025 | 120 | 22,362 (0%) | 0% | 135.6 | 16,276 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.73 per share. | 26 May 2025 | 123 | 16,383 (0%) | 0% | 136.7 | 16,818 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.73 per share. | 26 May 2025 | 91 | 16,292 (0%) | 0% | 136.7 | 12,442 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 138.65 per share. | 26 May 2025 | 62 | 16,230 (0%) | 0% | 138.6 | 8,596 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 2,468 | 17,297 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.57 per share. | 31 Jan 2025 | 791 | 16,506 (0%) | 0% | 165.6 | 130,966 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 4,470 | 4,470 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 1,967 | 14,829 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.51 per share. | 29 May 2024 | 190 | 12,947 (0%) | 0% | 214.5 | 40,757 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 180 | 13,336 (0%) | 0% | 217.2 | 39,098 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 180 | 13,336 (0%) | 0% | 217.2 | 39,098 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 170 | 13,166 (0%) | 0% | 217.2 | 36,926 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 122 | 13,214 (0%) | 0% | 217.2 | 26,500 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 114 | 13,052 (0%) | 0% | 217.2 | 24,762 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.21 per share. | 26 May 2024 | 77 | 13,137 (0%) | 0% | 217.2 | 16,725 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 253.70 per share. | 29 Feb 2024 | 5,000 | 13,550 (0%) | 0% | 253.7 | 1,268,500 | Common Stock |
| Charles River Laboratories... | Creamer Victoria L. | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 2,997 | 19,503 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 2,934 | 19,440 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria Creamer L. | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 953 | 18,550 (0%) | 0% | 220.3 | 209,927 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 924 | 18,516 (0%) | 0% | 220.3 | 203,539 | Common Stock |
| Charles River Laboratories... | L. Creamer Victoria | EVP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 225.00 per share. | 14 Dec 2023 | 5,526 | 16,506 (0%) | 0% | 225 | 1,243,350 | Common Stock |
| Charles River Laboratories... | L. Victoria Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 3,381 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Creamer Victoria L. | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 14 Dec 2023 | 3,381 | 19,887 (0%) | 0% | 144.7 | 489,129 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,145 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | L. Victoria Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 124.13 per share. | 14 Dec 2023 | 2,145 | 22,032 (0%) | 0% | 124.1 | 266,259 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 4,820 | 4,820 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 2,009 | 16,981 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 190 | 16,506 (0%) | 0% | 194.1 | 36,883 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 170 | 16,811 (0%) | 0% | 194.1 | 33,000 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 115 | 16,696 (0%) | 0% | 194.1 | 22,324 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.21 per share. | 01 Feb 2023 | 343 | 15,153 (0%) | 0% | 248.2 | 85,136 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.60 per share. | 01 Feb 2023 | 181 | 14,972 (0%) | 0% | 243.6 | 44,092 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 7,229 | 18,188 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.29 per share. | 27 Jan 2023 | 2,692 | 15,496 (0%) | 0% | 244.3 | 657,629 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 4,036 | 4,036 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,493 | 11,263 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 190 | 10,959 (0%) | 0% | 244.4 | 46,438 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 114 | 11,149 (0%) | 0% | 244.4 | 27,863 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 293.61 per share. | 22 Feb 2022 | 180 | 9,770 (0%) | 0% | 293.6 | 52,850 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 6,302 | 12,688 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.24 per share. | 28 Jan 2022 | 2,395 | 10,293 (0%) | 0% | 312.2 | 747,815 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 329.76 per share. | 28 Jan 2022 | 343 | 9,950 (0%) | 0% | 329.8 | 113,108 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Sale of securities on an exchange or to another person at price $ 415.24 per share. | 16 Aug 2021 | 6,917 | 6,386 (0%) | 0% | 415.2 | 2,872,236 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 3,380 | 3,381 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 16 Aug 2021 | 3,380 | 11,911 (0%) | 0% | 144.7 | 488,985 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 124.13 per share. | 16 Aug 2021 | 2,145 | 8,531 (0%) | 0% | 124.1 | 266,259 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 2,145 | 2,145 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.66 per share. | 16 Aug 2021 | 1,392 | 13,303 (0%) | 0% | 179.7 | 250,087 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 1,392 | 4,179 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 3,110 | 3,110 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 1,006 | 6,513 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.99 per share. | 28 May 2021 | 127 | 6,386 (0%) | 0% | 338.0 | 42,925 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.55 per share. | 22 Feb 2021 | 121 | 5,507 (0%) | 0% | 289.6 | 35,036 | Common Stock |
| Charles River Laboratories... | Victoria L. Creamer | EVP & Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.05 per share. | 01 Feb 2021 | 251 | 5,628 (0%) | 0% | 259.1 | 65,022 | Common Stock |